This article reviews the findings of relevant research, providing an overview of the oncogenic mechanisms of the FUS::DDIT3 fusion protein in MLS, as well as recent advancements in its therapy. This evidence concerns the gene DDIT3 and McLeod neuroacanthocytosis syndrome.